What changed
$DRI — AVOID 📊 | 6 MONTHS THESIS
🎯 FQ4 FY2027 (ends May) | reported Jun 25 | Rev $3.3B | EPS $3.66 vs $3.63 🟢 | Margin 12.2%
💡 Consensus expects ~$14.64 annual EPS with slow growth; our variant view is that the tiny beat signals no positive surprise, and the quant model's bottom 1% sector rank warns of underperformance—no meaningful mispricing exists.
🏢 Business Quality: 6/10
📊 Valuation: fair — trailing P/E 14.6x vs. peer range 13-18x, EV/EBITDA 12.2x, FCF yield unattractive given growth; no margin of safety for a long entry.
🔮 Catalyst: Q1 FY2027 earnings (Sept 2026)
⚖️ Avoid DRI: fair valuation, no catalyst edge, and bottom-quantile ranking argue for better opportunities elsewhere.